TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial

Daniel H. Palmer, Juan W. Valle, Yuk Ting Ma, Olusola Faluyi, John P. Neoptolemos, Trine Jensen Gjertsen, Berit Iversen, Jon Amund Eriksen, Anne-sophie Møller, Anne-kirsti Aksnes, Robert Miller, Svein Dueland

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)
135 Downloads (Pure)

Fingerprint

Dive into the research topics of 'TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences